Neuralink has chosen the University of Miami to host its PRIME Study, which investigates its revolutionary brain-computer interface (BCI) technology. This study is a crucial step towards enabling individuals with quadriplegia due to ALS or cervical spinal cord injuries to interact with devices using only their thoughts. The PRIME Study began earlier this year in Arizona and marks Neuralink's first major clinical trial in BCI technology. As the company prepares to scale up its operations, Elon Musk anticipates implanting the technology into up to 1,000 individuals by 2024, along with developing further innovations.
Neuralink announced its second U.S. site for the PRIME Study at the University of Miami, which aims to evaluate its brain-computer interface technology for individuals with quadriplegia.
The brain-computer interface allows paraplegic individuals to control devices using only their thoughts, showing promise for improving quality of life under the PRIME study.
Collection
[
|
...
]